These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 14509052)

  • 1. [Driving capacity and antidepressive drugs].
    Brunnauer A; Laux G
    Psychiatr Prax; 2003 May; 30 Suppl 2():S102-5. PubMed ID: 14509052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antidepressants and Driving Ability].
    Brunnauer A; Laux G
    Psychiatr Prax; 2003 May; 30(Suppl 2):102-105. PubMed ID: 13130350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of reboxetine and mirtazapine on driving simulator performance and psychomotor function in depressed patients.
    Brunnauer A; Laux G; David I; Fric M; Hermisson I; Möller HJ
    J Clin Psychiatry; 2008 Dec; 69(12):1880-6. PubMed ID: 19203476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressants and driver impairment: empirical evidence from a standard on-the-road test.
    Ramaekers JG
    J Clin Psychiatry; 2003 Jan; 64(1):20-9. PubMed ID: 12590619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressants and driving ability: results from a clinical study.
    Brunnauer A; Laux G; Geiger E; Soyka M; Möller HJ
    J Clin Psychiatry; 2006 Nov; 67(11):1776-81. PubMed ID: 17196059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New antidepressive drugs in comparison with classical tricyclics. Mechanism of action and clinical evaluation].
    Broocks A; Junghanns K; Thiel A; Gleiter CH; Bandelow B
    Fortschr Neurol Psychiatr; 2000 Jan; 68(1):17-24. PubMed ID: 10705571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute and subchronic effects of amitriptyline 25mg on actual driving in chronic neuropathic pain patients.
    Veldhuijzen DS; van Wijck AJ; Verster JC; Kenemans JL; Kalkman CJ; Olivier B; Volkerts ER
    J Psychopharmacol; 2006 Nov; 20(6):782-8. PubMed ID: 16401650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma amitriptyline level after acute administration, and driving performance in healthy volunteers.
    Iwamoto K; Kawamura Y; Takahashi M; Uchiyama Y; Ebe K; Yoshida K; Iidaka T; Noda Y; Ozaki N
    Psychiatry Clin Neurosci; 2008 Oct; 62(5):610-6. PubMed ID: 18950383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of imipramine, fluvoxamine and depressive mood on autonomic cardiac functioning in major depressive disorder.
    Volkers AC; Tulen JH; van den Broek WW; Bruyn JA; Passchier J; Pepplinkhuizen L
    Pharmacopsychiatry; 2004 Jan; 37(1):18-25. PubMed ID: 14750044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Driving fitness in therapy with antidepressive drugs].
    Soyka M; Dittert S; Gartenmeier A; Schäfer M
    Versicherungsmedizin; 1998 Apr; 50(2):59-66. PubMed ID: 9587241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of polypharmacological antidepressive treatment on central nervous information processing of depressed patients: implications for fitness to drive.
    Grabe HJ; Wolf T; Grätz S; Laux G
    Neuropsychobiology; 1998; 37(4):200-4. PubMed ID: 9648128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoxetine (prozac) in depresion of adults.
    Kocur J; Rydzynski Z; Duszyk S; Gruszczynski W; Trendak W
    Homeost Health Dis; 1991; 33(5-6):295. PubMed ID: 18265505
    [No Abstract]   [Full Text] [Related]  

  • 13. Clomipramine, fluoxetine and CYP2D6 metabolic capacity in depressed patients.
    Vandel P; Haffen E; Nezelof S; Broly F; Kantelip JP; Sechter D
    Hum Psychopharmacol; 2004 Jul; 19(5):293-8. PubMed ID: 15252821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venlafaxine-mirtazapine combination in the treatment of persistent depressive illness.
    Hannan N; Hamzah Z; Akinpeloye HO; Meagher D
    J Psychopharmacol; 2007 Mar; 21(2):161-4. PubMed ID: 17329295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of haloperidol and risperidone on psychomotor performance relevant to driving ability in schizophrenic patients compared to healthy controls.
    Soyka M; Winter C; Kagerer S; Brunnauer M; Laux G; Möller HJ
    J Psychiatr Res; 2005 Jan; 39(1):101-8. PubMed ID: 15504428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescribing of venlafaxine and dosulepin in primary care.
    McAllister-Williams RH; Foran K; Forrest S; Ingram G; McMahon L; Taylor M; Rajwal MS; Cornwall PL
    J Psychopharmacol; 2006 Nov; 20(6):868. PubMed ID: 17060347
    [No Abstract]   [Full Text] [Related]  

  • 17. [Test performance with minimal alcoholic intoxication].
    Bartl G; Lager F; Domesle L
    Blutalkohol; 1996 Jan; 33(1):1-16. PubMed ID: 8777031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mental illness and simulated driving: before and during treatment.
    Bech P
    Pharmakopsychiatr Neuropsychopharmakol; 1975 Jul; 8(4):143-50. PubMed ID: 1233517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of psychoactive drugs on car driving ability].
    Brunnauer A; Laux G
    Dtsch Med Wochenschr; 2008 Jun; 133 Suppl 2():S38-40. PubMed ID: 18548369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of fluoxetine on fine motor performance in dysthymia: an 8-week, nonrandomized, open-label study.
    Schrijvers D; Maas YJ; Sabbe BG
    Clin Ther; 2009 Jan; 31(1):123-9. PubMed ID: 19243713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.